CSL Ltd (CMXHF)
191.79
+0.79
(+0.41%)
USD |
OTCM |
Jun 25, 16:00
CSL Enterprise Value: 105.76B for June 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 25, 2024 | 105.76B |
June 24, 2024 | 105.38B |
June 21, 2024 | 105.50B |
June 20, 2024 | 105.01B |
June 18, 2024 | 105.88B |
June 17, 2024 | 103.68B |
June 14, 2024 | 104.17B |
June 13, 2024 | 105.86B |
June 12, 2024 | 103.20B |
June 11, 2024 | 102.62B |
June 10, 2024 | 103.70B |
June 07, 2024 | 104.41B |
June 06, 2024 | 105.86B |
June 05, 2024 | 102.24B |
June 04, 2024 | 103.56B |
June 03, 2024 | 104.41B |
May 31, 2024 | 104.41B |
May 30, 2024 | 102.33B |
May 29, 2024 | 103.47B |
May 28, 2024 | 101.75B |
May 24, 2024 | 100.56B |
May 23, 2024 | 101.29B |
May 22, 2024 | 101.29B |
May 21, 2024 | 100.93B |
May 20, 2024 | 102.78B |
Date | Value |
---|---|
May 17, 2024 | 102.38B |
May 16, 2024 | 104.89B |
May 15, 2024 | 102.50B |
May 14, 2024 | 100.54B |
May 13, 2024 | 99.99B |
May 10, 2024 | 100.18B |
May 09, 2024 | 100.91B |
May 08, 2024 | 100.91B |
May 07, 2024 | 100.74B |
May 06, 2024 | 98.87B |
May 03, 2024 | 100.08B |
May 02, 2024 | 98.22B |
May 01, 2024 | 98.22B |
April 30, 2024 | 98.49B |
April 29, 2024 | 98.20B |
April 26, 2024 | 98.03B |
April 25, 2024 | 99.31B |
April 24, 2024 | 99.31B |
April 23, 2024 | 98.13B |
April 22, 2024 | 98.13B |
April 19, 2024 | 96.80B |
April 18, 2024 | 96.80B |
April 17, 2024 | 96.46B |
April 16, 2024 | 97.64B |
April 15, 2024 | 100.42B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
70.82B
Minimum
Aug 06 2019
116.89B
Maximum
Feb 03 2023
96.11B
Average
96.99B
Median
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 3.042M |
Immutep Ltd | -- |
Opthea Ltd | 2.833M |
Enterprise Value Related Metrics
Earnings Yield | 2.65% |
Operating Earnings Yield | 2.71% |
Normalized Earnings Yield | 2.654 |